191 related articles for article (PubMed ID: 10634393)
1. Recombinant human thyrotropin for the diagnosis and treatment of a highly functional metastatic struma ovarii.
Rotman-Pikielny P; Reynolds JC; Barker WC; Yen PM; Skarulis MC; Sarlis NJ
J Clin Endocrinol Metab; 2000 Jan; 85(1):237-44. PubMed ID: 10634393
[TBL] [Abstract][Full Text] [Related]
2. A case of metastatic struma ovarii treated with 131I therapy: focus on preservation of fertility and selected review of the literature.
Salvatori M; Dambra DP; D'Angelo G; Conte LL; Locantore P; Zannoni G; Campo V; Campo S
Gynecol Endocrinol; 2008 Jun; 24(6):312-9. PubMed ID: 18584410
[TBL] [Abstract][Full Text] [Related]
3. Malignant struma ovarii: an unusual presentation.
Checrallah A; Medlej R; Saadé C; Khayat G; Halaby G
Thyroid; 2001 Sep; 11(9):889-92. PubMed ID: 11575860
[TBL] [Abstract][Full Text] [Related]
4. 131I therapy using rhTSH stimulation and dosimetry in metastatic malignant struma ovarii.
Yan J; Lewis DH; Benoit MF; Eary JF; Mankoff DA
Clin Nucl Med; 2014 Jan; 39(1):102-5. PubMed ID: 24152665
[TBL] [Abstract][Full Text] [Related]
5. Struma ovarii maligna.
Matysiak-Grzes M; Fischbach J; Gut P; Klimowicz A; Gryczynska M; Wasko R; Ruchala M
Neuro Endocrinol Lett; 2013; 34(2):97-101. PubMed ID: 23645304
[TBL] [Abstract][Full Text] [Related]
6. Extensive peritoneal implant metastases of malignant struma ovarii treated by thyroidectomy and 131I therapy: A case report.
Wu M; Hu F; Huang X; Tan Z; Lei C; Duan D
Medicine (Baltimore); 2018 Dec; 97(51):e13867. PubMed ID: 30572559
[TBL] [Abstract][Full Text] [Related]
7. Is diagnostic iodine-131 scanning with recombinant human TSH useful in the follow-up of differentiated thyroid cancer after thyroid ablation?
Mazzaferri EL; Kloos RT
J Clin Endocrinol Metab; 2002 Apr; 87(4):1490-8. PubMed ID: 11932270
[TBL] [Abstract][Full Text] [Related]
8. Radioiodine treatment with 30 mCi after recombinant human thyrotropin stimulation in thyroid cancer: effectiveness for postsurgical remnants ablation and possible role of iodine content in L-thyroxine in the outcome of ablation.
Barbaro D; Boni G; Meucci G; Simi U; Lapi P; Orsini P; Pasquini C; Piazza F; Caciagli M; Mariani G
J Clin Endocrinol Metab; 2003 Sep; 88(9):4110-5. PubMed ID: 12970272
[TBL] [Abstract][Full Text] [Related]
9. Examining recombinant human TSH primed ¹³¹I therapy protocol in patients with metastatic differentiated thyroid carcinoma: comparison with the traditional thyroid hormone withdrawal protocol.
Rani D; Kaisar S; Awasare S; Kamaldeep ; Abhyankar A; Basu S
Eur J Nucl Med Mol Imaging; 2014 Sep; 41(9):1767-80. PubMed ID: 24687139
[TBL] [Abstract][Full Text] [Related]
10. Incidental diagnosis of struma ovarii after thyroidectomy for thyroid cancer: functional imaging studies and follow-up.
Ghander C; Lussato D; Conte Devolx B; Mundler O; Taïeb D
Gynecol Oncol; 2006 Aug; 102(2):378-80. PubMed ID: 16516952
[TBL] [Abstract][Full Text] [Related]
11. Typical thyroid-type carcinoma arising in struma ovarii: a report of 4 cases and review of the literature.
Roth LM; Miller AW; Talerman A
Int J Gynecol Pathol; 2008 Oct; 27(4):496-506. PubMed ID: 18753973
[TBL] [Abstract][Full Text] [Related]
12. Recombinant human thyroid-stimulating hormone (rhTSH) in the radioablation of well-differentiated thyroid cancer: preliminary therapeutic experience.
Perros P
J Endocrinol Invest; 1999; 22(11 Suppl):30-4. PubMed ID: 10727003
[TBL] [Abstract][Full Text] [Related]
13. Papillary thyroid carcinoma in Struma Ovarii.
Khatchapuridze K; Kekelidze N; Tsitsishvili Z; Mchedlishvili M; Kordzaia D
Gynecol Endocrinol; 2020 Aug; 36(8):749-752. PubMed ID: 32041443
[TBL] [Abstract][Full Text] [Related]
14. Struma ovarii and the thyroid surgeon.
Gunasekaran S; Kopecka E; Maung KH; England RJ
J Laryngol Otol; 2012 Aug; 126(8):858-60. PubMed ID: 22624934
[TBL] [Abstract][Full Text] [Related]
15. The lack of consensus in management of malignant struma ovarii.
González Aguilera B; Guerrero Vázquez R; Gros Herguido N; Sánchez Gallego F; Navarro González E
Gynecol Endocrinol; 2015 Apr; 31(4):258-9. PubMed ID: 25539066
[TBL] [Abstract][Full Text] [Related]
16. Metastatic struma ovarii: late presentation, unusual features and multiple radioactive iodine treatments.
Zekri JM; Manifold IH; Wadsley JC
Clin Oncol (R Coll Radiol); 2006 Dec; 18(10):768-72. PubMed ID: 17168212
[TBL] [Abstract][Full Text] [Related]
17. Metastatic struma ovarii: the burden of truth.
McDougall IR
Clin Nucl Med; 2006 Jun; 31(6):321-4. PubMed ID: 16714888
[TBL] [Abstract][Full Text] [Related]
18. Ablation of thyroid residues with 30 mCi (131)I: a comparison in thyroid cancer patients prepared with recombinant human TSH or thyroid hormone withdrawal.
Pacini F; Molinaro E; Castagna MG; Lippi F; Ceccarelli C; Agate L; Elisei R; Pinchera A
J Clin Endocrinol Metab; 2002 Sep; 87(9):4063-8. PubMed ID: 12213846
[TBL] [Abstract][Full Text] [Related]
19. rhTSH-aided radioiodine ablation and treatment of differentiated thyroid carcinoma: a comprehensive review.
Luster M; Lippi F; Jarzab B; Perros P; Lassmann M; Reiners C; Pacini F
Endocr Relat Cancer; 2005 Mar; 12(1):49-64. PubMed ID: 15788638
[TBL] [Abstract][Full Text] [Related]
20. Highly differentiated follicular carcinoma arising from struma ovarii: a report of 3 cases, a review of the literature, and a reassessment of so-called peritoneal strumosis.
Roth LM; Karseladze AI
Int J Gynecol Pathol; 2008 Apr; 27(2):213-22. PubMed ID: 18317221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
